Older Patients With Hodgkin Lymphoma: A Contemporary Review
{{output}}
Older patients age >60 years with advanced-stage cHL have historically had poorer outcomes, attributed to comorbid conditions, performance status, and chemotherapy intolerance. The use of an anthracycline-based chemotherapy backbone has shown strong correlatio... ...